Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Bml Capital Management, Llc > Profile

Instuitional Investor - Bml Capital Management, Llc

Fund Profile
Filing Period:
Fund Name: Bml Capital Management, Llc
Portfolio Value $187,619,016
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Aclaris Therapeutics Inc.
 ACRS 10,955,000 $57,623,300 30.71%
2.
Atea Pharmaceuticals Inc.
 AVIR 6,753,658 $35,186,558 18.75%
3.
Engene Therapeutics Inc
 6,669,908 $13,339,816 7.11%
4.
Pmv Pharmaceuticals Inc.
 PMVP 7,330,000 $12,241,100 6.52%
5.
Kraft Heinz Co
 KHC 475,000 $10,792,000 5.75%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.